Spots Global Cancer Trial Database for Premedication to Reduce Amivantamab Associated Infusion Related Reactions
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Premedication to Reduce Amivantamab Associated Infusion Related Reactions
Official Title: Subcutaneous Methotrexate, Oral Dexamethasone or Oral Montelukast for the Prevention of Infusion Related Reaction Associated With Amivantamab, an EGFR-MET Bispecific Antibody, Among Post-osimertinib Treated EGFRm NSCLC; SKIPPirr, a Phase 2 Study
Study ID: NCT05663866
Conditions
Study Description
Brief Summary: The purpose of the study is to separately assess the potential of dexamethasone, montelukast and methotrexate administration, prior to amivantamab infusion given through a needle in the vein, to decrease the incidence and/or severity of first-dose infusion related reactions.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Compassionate Cancer Care, Fountain Valley, California, United States
Virginia Cancer Specialists, Fairfax, Virginia, United States
UW Medicine Valley Medical Center, Renton, Washington, United States
CHU Brest, Brest, , France
Centre Leon Berard, Lyon Cedex 8, , France
Hopital Cochin, Paris, , France
Hopital Europeen Georges-Pompidou, Paris, , France
CHU Rouen Hopital Charles Nicolle, Rouen, , France
Nouvel Hopital Civil - CHU Strasbourg, Strasbourg CEDEX, , France
Chungbuk National University Hospital, Cheongju-si, , Korea, Republic of
National Cancer Center, Gyeonggi-do, , Korea, Republic of
Seoul National University Bundang Hospital, Gyeonggi-do, , Korea, Republic of
Gachon University Gil Medical Center, Incheon, , Korea, Republic of
Chonnam National University Hwasun Hospital, Jeollanam-do, , Korea, Republic of
Asan Medical Center, Seoul, , Korea, Republic of
Hosp. de La Santa Creu I Sant Pau, Barcelona, , Spain
Hosp. Univ. Vall D Hebron, Barcelona, , Spain
Hosp. Univ. Quiron Dexeus, Barcelona, , Spain
Hosp. San Pedro de Alcantara, Cáceres, , Spain
Hosp. de Jerez de La Frontera, Jerez de la Frontera, , Spain
Inst. Cat. Doncologia-H Duran I Reynals, L Hospitalet De Llobregat, , Spain
Hosp. Gral. Univ. Gregorio Maranon, Madrid, , Spain
Hosp. Univ. 12 de Octubre, Madrid, , Spain
Hosp. Virgen de La Victoria, Malaga, , Spain
Hosp. Univ. Son Espases, Palma de Mallorca, , Spain
Hosp. Clinico Univ. de Santiago, Santiago de Compostela, , Spain
Inst. Valenciano de Oncologia, Valencia, , Spain
Hosp. Gral. Univ. Valencia, Valencia, , Spain
Hosp. Clinico Univ. Lozano Blesa, Zaragoza, , Spain
Changhua Christian Hospital, ChangHua, , Taiwan
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, , Taiwan
Taichung Veterans General Hospital, Taichung, , Taiwan
Chi-Mei Medical Center, Liouying, Tainan City, , Taiwan
Taipei Medical University, Taipei City, , Taiwan
National Taiwan University Hospital, Taipei, , Taiwan
Taipei Veterans General Hospital, Taipei, , Taiwan
Contact Details
Name: Janssen Research & Development, LLC Clinical Trial
Affiliation: Janssen Research & Development, LLC
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
